LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 52 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,976 | +1.6% | 4,000,000 | 0.0% | 0.04% | +5.9% |
Q4 2022 | $3,914 | -99.8% | 4,000,000 | +100.0% | 0.03% | +47.8% |
Q3 2022 | $1,945,000 | -0.2% | 2,000,000 | 0.0% | 0.02% | +9.5% |
Q2 2022 | $1,949,000 | -0.3% | 2,000,000 | 0.0% | 0.02% | +16.7% |
Q1 2022 | $1,955,000 | -3.0% | 2,000,000 | 0.0% | 0.02% | 0.0% |
Q4 2021 | $2,016,000 | -0.1% | 2,000,000 | 0.0% | 0.02% | -18.2% |
Q3 2021 | $2,019,000 | +1.9% | 2,000,000 | 0.0% | 0.02% | +10.0% |
Q2 2021 | $1,982,000 | -91.9% | 2,000,000 | -91.5% | 0.02% | -91.8% |
Q1 2021 | $24,392,000 | +19.2% | 23,500,000 | +9.3% | 0.24% | +4.3% |
Q4 2020 | $20,467,000 | +140.4% | 21,500,000 | +130.3% | 0.24% | +117.6% |
Q3 2020 | $8,515,000 | – | 9,337,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|